Skip to main content

Recombinant Human Integrin alpha V beta 5 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 2528-AV

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
2528-AV-050

Key Product Details

Source

CHO

Structure / Form

Noncovalently-linked heterodimer

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Integrin alpha V beta 5 protein
Human Integrin alphaV
(Phe31-Val992)
Accession # P06756
His-Pro GGGSGGGS Acidic Tail 6-His tag
Human Integrin beta5
(Gly24-Asn719)
Accession # P18084
His-Pro GGGSGGGS Basic Tail
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Phe31 ( alphaV subunit) & Gly24 ( beta5 subunit)

Predicted Molecular Mass

115.4 kDa ( alphaV subunit) & 84.8 kDa ( beta5 subunit)

SDS-PAGE

100-155 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human Vitronectin (Catalog # 2308-VN) is coated at 1 μg/mL, Recombinant Human Integrin  alphaV beta5 binds with an apparent KD <0.5 nM.

Formulation, Preparation and Storage

2528-AV
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution
Reconstitute at 200 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Integrin alpha V beta 5

Integrin alphaV beta5 is one of five alphaV integrins and the only known beta5 integrin (1-3). The non-covalent heterodimer of 170 kDa alphaV and 100‑110 kDa beta5 integrin type I transmembrane glycoprotein subunits is expressed on a wide variety of cell types including keratinocytes, fibroblasts, adhesive monocytes, embryonic stem cells, and select endothelium and epithelium (4‑8). alphaV beta5 binds ligands containing an RGD motif, notably vitronectin (1‑10). The 962 aa human alphaV extracellular domain (ECD) shares 92-95% aa sequence identity with mouse, rat and cow alphaV, while the 696 aa human beta5 ECD shares 89%-93% aa identity with mouse, rat, bovine, equine, and canine beta5. The alphaV ECD contains an N-terminal beta- propeller structure, followed by domains termed thigh, calf-1 and calf-2 (1). The 799 aa beta5 contains a vWFA domain within the ECD, which interacts with the alphaV beta-propeller to form a binding domain. Each subunit has a transmembrane sequence and a short cytoplasmic tail. Potential beta5 isoforms include a 691 aa form with an alternate start site at aa 109, a 958 aa form with an alternate N‑terminus, and a 795 aa form with an alternate C‑terminus. Post-translational modifications, such as proteolytic cleavage of the alphaV subunit or phosphorylation of the beta5 cytoplasmic tail, can increase endocytic turnover of the alphaV beta5 protein and/or promote cell migration (7‑10). Growth factors that increase PKC activity, such as VEGF or TGF‑ alpha, promote alphaV beta5-mediated angiogenesis while alphaV beta3, which may be expressed in the same cell, responds to FGF-basic and TNF‑ alpha (11). An inhibitor of both down‑regulates tumor angiogenesis (12). During lung inflammation, up‑regulation of alphaV beta5 on myofibroblasts or infiltrating lymphocytes may contribute to fibrosis by freeing TGF‑ beta from latency (13, 14). On retinal pigment epithelia, alphaV beta5 is important for normal diurnal phagocytosis of outer rod segments, and contributes to adhesion of retinal cells (15).

References

  1. Hynes, R. O. (2002) Cell 110:673.
  2. Suzuki, S. et al. (1987) J. Biol. Chem. 262:14080.
  3. Suzuki, S. et al. (1990) Proc. Natl. Acad. Sci. USA 87:5354.
  4. Smith, J.W. et al. (1990) J. Biol. Chem. 265:11008.
  5. Pasqualini, R. et al. (1993) J. Cell Sci. 105:101.
  6. Braam, S.R. et al. (2008) Stem Cells 26:2257.
  7. Memmo, L.M. and P. McKeown-Longo (1998) J. Cell Sci. 111:425.
  8. Kim, J.P. et al. (1994) J. Biol. Chem. 269:26926.
  9. Berthet, V. et al. (2004) FEBS Lett. 557:159.
  10. Li, Z. et al. (2010) Mol. Biol. Cell 21:3317.
  11. Friedlander, M. et al. (1995) Science 270:1500.
  12. Desgrosellier, J.S. and D.A. Cheresh (2010) Nat. Rev. Cancer 10:9.
  13. Wipff, P.J. et al. (2007) J. Cell Biol. 179:1311.
  14. Luzina, I.G. et al. (2009) Arthritis Rheum. 60:1530.
  15. Nandrot, E.F. et al. (2004) J. Exp. Med. 200:1539.

Alternate Names

CD51, integrin subunit alpha V, ITGAV, MSK8, VNRA, VTNR

Entrez Gene IDs

3685 (Human)

Gene Symbol

ITGAV

Additional Integrin alpha V beta 5 Products

Product Documents for Recombinant Human Integrin alpha V beta 5 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Integrin alpha V beta 5 Protein, CF

For research use only

Loading...
Loading...
Loading...
Loading...